NYU Langone Health

Castle Connolly Names 40 Physicians within The Prelude Network® as 2024 Top Doctors

Retrieved on: 
Tuesday, February 13, 2024
Fertility preservation, IUI, Education, Reproductive medicine, Physician, Dream, IVF, Parent, Pleasure, Castle Connolly Medical, PGT, NYU, Faculty, Prelude, Vitrification, Artificial insemination, NYU Langone Health, Patient, Genetic testing, Nursing

HOUSTON, Feb. 13, 2024 /PRNewswire/ -- The Prelude Network® (Prelude), the largest and fastest-growing network of fertility providers in North America, today celebrates 40 of its physicians across 14 clinics within its expansive network who are named a 2024 Top Doctor by Castle Connolly.

Key Points: 
  • The recognition methodology has been vetted and endorsed by the Castle Connolly Medical Advisory Board .
  • Prelude specialists include innovators in fertility care who have pioneered some of today's most advanced reproductive technologies, including vitrification, fertility preservation, and preimplantation genetic testing (PGT).
  • Dr. Jamie Grifo , Program Director at NYU Langone Fertility and Chief Executive Physician of Inception, was named a 2024 Castle Connolly Top Doctor for the 25th year in a row.
  • "Inception Fertility extends its heartfelt congratulations to our incredible physicians who are so deserving of the Top Doctor recognition," says TJ Farnsworth, Founder and CEO of Inception Fertility.

Plant-Based Diet Tied to Improved Sexual Health in Men Treated for Prostate Cancer

Retrieved on: 
Tuesday, February 13, 2024
Master of Science, Bangladesh Technical Education Board, Nut, Prostate Cancer Foundation, Obstruction, Diabetes, Population health, Diet, National Institutes of Health, Prostate cancer, Dentist, Quality of life, Public health, Plant, Urinary incontinence, Harvard University, Hope, Veterinarian, Dietary fiber, SCM, Hot, Erectile dysfunction, Radiation, Meat, Risk, Pharmacist, University, NYU, Vegetable, History, Incontinence, Doctor of Science, White, Patient, MPH, Eating, Depression, Disease, NYU Langone Health, Male, Optometry, Research, Irritation, Dietary supplement

Chan School of Public Health, the analysis of more than 3,500 men with prostate cancer explored whether eating a more plant-based diet was associated with quality-of-life issues that often arise after treatment.

Key Points: 
  • Chan School of Public Health, the analysis of more than 3,500 men with prostate cancer explored whether eating a more plant-based diet was associated with quality-of-life issues that often arise after treatment.
  • Similarly, the results revealed up to 14% better scores for urinary health, with fewer instances of incontinence, obstruction, and irritation.
  • Prostate cancer is among the most common and deadliest forms of cancer among American men, according to the U.S. Centers for Disease Control and Prevention.
  • Funding for the study was provided by National Institutes of Health grant U01CA167552, New York State Department of Health, Tricia and Michael Berns, and the Prostate Cancer Foundation.

NYU Langone Orthopedic Surgeons Present Latest Clinical Findings & Research at AAOS 2024

Retrieved on: 
Monday, February 12, 2024
Surgeon, Injury, Health, Tears, Unilateralism, Patient, MRI, Elective surgery, Rate, Weight, Connective tissue, Annual general meeting, Faculty, Length of stay, SAN, American Journal, Physician, Orthopedic surgery, Anesthesia, NYU Langone Health, Sports medicine, Walter, News, Anatomy, Anterior cruciate ligament, AAOS, PTS, Research, Insurance, American Academy, Hip fracture, Division, Magnetic resonance imaging, AMS, Weight loss, Risk, ACL, Knee, Hip, Body mass index, Nursing

SAN FRANCISCO, Feb. 12, 2024 /PRNewswire/ -- Experts from NYU Langone Orthopedics will present their latest clinical findings and research discoveries at the American Academy of Orthopaedic Surgeons' (AAOS) 2024 Annual Meeting, February 12-16, in San Francisco.

Key Points: 
  • SAN FRANCISCO, Feb. 12, 2024 /PRNewswire/ -- Experts from NYU Langone Orthopedics will present their latest clinical findings and research discoveries at the American Academy of Orthopaedic Surgeons' (AAOS) 2024 Annual Meeting, February 12-16, in San Francisco.
  • "This year's impressive group of presentations at the nation's premier orthopedic meeting is a testament to why NYU Langone Orthopedics endeavors to always deliver world-class care to our patients."
  • At this year's meeting, faculty of NYU Langone Orthopedics will present 39 posters, 31 e-posters, 34 papers, 31 videos, and 21 symposia, courses, specialty programs, and special sessions.
  • Surgeons at NYU Langone endeavored to determine short-term patient outcomes using these minimally invasive, precision-based technologies.

Pioneering Technique Reveals New Layer of Human Gene Regulation

Retrieved on: 
Friday, February 9, 2024
Human, NYU Langone Health, RNA, Chromatin, Tick, Cell division, Cancer, Howard Hughes Medical Institute, IIS, DNA repair, Genetic code, Bangladesh Technical Education Board, Protein, NYU, RNA polymerase II, Multimedia, DNA, Genome, Biochemistry, Gene expression, Pharmacology, Gene, Bacteria, National Institutes of Health, Ageing, Doctor of Philosophy, Disease, Vaccine

Now a new study led by Nudler's team at NYU Langone Health reveals that their new technique, Long Range Cleavage sequencing (LORAX-seq), can directly detect where backtracking events begin and end.

Key Points: 
  • Now a new study led by Nudler's team at NYU Langone Health reveals that their new technique, Long Range Cleavage sequencing (LORAX-seq), can directly detect where backtracking events begin and end.
  • The results also suggest that persistent backtracking occurs frequently throughout genomes, happens more often near certain gene types, and has functions well beyond DNA repair.
  • "If further work expands our findings to different developmental programs and pathological conditions, backtracking may be akin to epigenetics, the discovery of which revealed a surprising new layer of gene regulation without changing the DNA code."
  • Locked, backtracked complexes are less likely to be rescued by TFIIS-driven cleavage, and more likely to delay transcription of the gene involved.

Preterm Births Linked to 'Hormone Disruptor' Chemicals May Cost United States Billions

Retrieved on: 
Tuesday, February 6, 2024
ECHO, University, Columbia University, NYU, Cosmetics, Phthalate, Bangladesh Technical Education Board, Champaign–Urbana metropolitan area, Wayne State University, Lancet, NYU Langone Health, Food, National Institutes of Health, DEHP, MPH, Emory University, Woman, Johns Hopkins University, Population health, MPP, Blood, DIDP, Northeastern University, Infant, Risk, Doctor of Philosophy, Rutgers University, Cancer, Gestational age, Triangle Park (Quezon City), Racism, Mother, Research, Obesity, Preterm birth, RTI International, The Lancet, Pregnancy, Doctor of Science, Dartmouth College, Diabetes, Pennsylvania State University, Urine, Hormone, Achievement Medal, Pediatrics, Dietary supplement

Then, the team looked for associations between these metabolite levels and preterm births.

Key Points: 
  • Then, the team looked for associations between these metabolite levels and preterm births.
  • "Otherwise, investigators are likely going to find the same study results in another few years about the next group of chemicals used as replacements."
  • California, among a few states, has banned some use of phthalates in consumer products, as have European Union member states.
  • Trasande cautions that further research is needed to better understand the specific mechanisms behind the link between phthalate exposure and preterm birth.

GrayMatters Health Announces Pioneering Study Highlighting Safety and Efficacy of Self-Neuromodulation for PTSD

Retrieved on: 
Tuesday, February 6, 2024
PTSD, Checklist, Research, Magnetic resonance, Psychiatry, Patient, Safety, FDA, GMH, NYU Langone Health, EFP, Computer simulation, Patient Health Questionnaire, Entrepreneurship, Psychotherapy, Mental health, DSM-5, Journal, EEG, Health, Woman

HAIFA, Israel and NEW YORK, Feb. 6, 2024 /PRNewswire/ -- GrayMatters Health (GMH), developer of digital self-neuromodulation therapies for mental health care, announces the publication of a peer-reviewed article in the Journal of Psychiatry Research demonstrating the safety and efficacy of its FDA-cleared Prism for PTSD device. The prospective, single arm, multi-site, open label trial evaluated men, women, and treatment-resistant combat veterans with chronic post-traumatic stress disorder (PTSD).

Key Points: 
  • The prospective, single arm, multi-site, open label trial evaluated men, women, and treatment-resistant combat veterans with chronic post-traumatic stress disorder (PTSD).
  • Prism for PTSD is the first self-neuromodulation device to receive FDA clearance as a prescribed adjunct to standard-of-care for PTSD.
  • The treatment, now available in select clinics in the United States, digitizes brain activity associated with PTSD to scientifically help patients gain control of their PTSD symptoms.
  • Prism for PTSD uses a computer simulation and EEG headset to create a novel, immersive environment for training individuals to self-modulate an amygdala-based biomarker associated with PTSD.

NYU Langone Health Awarded $13 Million to Create National Center to Promote Diabetes Equity Research

Retrieved on: 
Tuesday, February 6, 2024
Olive, Partnership, NYU Langone Health, Digestive, Family, Kidney failure, Public, Prediabetes, Nerve, Research, Health equity, MD, Caregiver, Patient, UCLA, Kidney, Paratriathlon, Olive View–UCLA Medical Center, School, Organization, American Diabetes Association, Social medicine, MPH, Diabetes, Education, AUC, Trust, Bangladesh Technical Education Board, Community, Type 2 diabetes, Workforce, African Americans, Pharmaceutical industry

To generate more community-engaged diabetes research, the National Institute of Diabetes and Digestive and Kidney Diseases, a division of the National Institutes of Health, has pledged $13 million to NYU Langone Health, Albert Einstein School of Medicine/Montefiore Health System, and UCLA School of Medicine to create the National Center for Engagement in Diabetes Equity Research (CEDER), the first of its kind.

Key Points: 
  • To generate more community-engaged diabetes research, the National Institute of Diabetes and Digestive and Kidney Diseases, a division of the National Institutes of Health, has pledged $13 million to NYU Langone Health, Albert Einstein School of Medicine/Montefiore Health System, and UCLA School of Medicine to create the National Center for Engagement in Diabetes Equity Research (CEDER), the first of its kind.
  • Co-led by Nadia Islam, PhD, associate professor in the Institute for Excellence in Health Equity at NYU Langone, CEDER will create a centralized national infrastructure designed to foster community engagement and participation of diverse populations in Type 2 diabetes research.
  • "It is our hope that everyone committed to advancing equity in diabetes research and care can access the support and mentorship they need."
  • CEDER is funded by the National Institute of Diabetes and Digestive and Kidney Diseases.

Police Seizures of Psychedelic Drugs Are Soaring Throughout the United States

Retrieved on: 
Tuesday, February 6, 2024
Psilocybin, NYU Langone Health, University, Congress, Seizure, Research, Population health, Acute stress disorder, Substance dependence, Columbia University, HIDTA, NYU, High, National Institutes of Health, MPH, Depression, Mescaline, Illegal drug trade, Fungus, Sale, Bangladesh Technical Education Board, Cancer, LSD, Drug

Their analysis of national and state-level trafficking data revealed that across the country, seizures of psilocybin rose from 402 confiscations in 2017 to 1,393 confiscations in 2022.

Key Points: 
  • Their analysis of national and state-level trafficking data revealed that across the country, seizures of psilocybin rose from 402 confiscations in 2017 to 1,393 confiscations in 2022.
  • The amount of the seized drugs nearly quadrupled, from 226 kilograms to 844 kilograms in the same time frame.
  • "Our findings, which uncover an increase in confiscations of psilocybin, suggest that popularity and availability of this psychedelic may be increasing," said study lead author Joseph Palamar, PhD, MPH.
  • For example, some of the reports in the data reference large shipments that may have been headed to other states for sale.

Kleine-Levin Syndrome Foundation Relaunches Medical Advisory Board

Retrieved on: 
Tuesday, January 30, 2024
Multimedia, Psychiatry, NYU Langone Health, SAN, Narcolepsy, Knowledge, Research, KLS, Caregiver, Patient, Neurology, Behavioural sciences, Medicine, Sleep, FRCP, Assistant, Doctor of Philosophy, Kleine–Levin syndrome, King's College, Pharmaceutical industry

SAN JOSE, Calif., Jan. 30, 2024 /PRNewswire/ -- The Kleine-Levin Syndrome Foundation today relaunched its Medical Advisory Board to help accelerate scientific understanding about KLS. The volunteer members of the Medical Advisory Board encourage scientific research to advance the search for a cause and a cure for KLS, provide objective medical knowledge to build awareness about KLS, and offer guidance for KLS patients and their caregivers.

Key Points: 
  • Members help encourage scientific inquiry; provide patients evidence-based information and guidance
    SAN JOSE, Calif., Jan. 30, 2024 /PRNewswire/ -- The Kleine-Levin Syndrome Foundation today relaunched its Medical Advisory Board to help accelerate scientific understanding about KLS.
  • "The KLS Foundation Board of Directors is grateful for the extensive knowledge and expertise of these respected researchers and clinicians," said Kleine-Levin Syndrome Foundation President Steve Maier, who experienced 18 KLS episodes from age 13-27.
  • "The Medical Advisory Board will provide the evidence-based guidance sought by so many KLS patients and their caregivers."
  • The relaunched Medical Advisory Board is composed of experts who volunteer their time and knowledge in many medical disciplines relating to KLS, including sleep disorders, neurology, and psychiatry.

NYU Langone Officially Opens State-of-the-Art Ambulatory Care Center in Former Garden City Bloomingdale's Building, its Largest on Long Island

Retrieved on: 
Tuesday, January 30, 2024
NYU Langone Health, MD, Patient, NYU, Franklin Avenue, Trustee, Trust, Bloomingdale's, Health, Nursing

NEW YORK, Jan. 30, 2024 /PRNewswire/ -- Expanding its award-winning health network , NYU Langone Health this month opened its largest ambulatory care center on Long Island, converting the former Bloomingdale's and Sears building in Garden City into a state-of-the-art, 260,000-square foot facility that houses 32 clinical specialties.

Key Points: 
  • NEW YORK, Jan. 30, 2024 /PRNewswire/ -- Expanding its award-winning health network , NYU Langone Health this month opened its largest ambulatory care center on Long Island, converting the former Bloomingdale's and Sears building in Garden City into a state-of-the-art, 260,000-square foot facility that houses 32 clinical specialties.
  • NYU Langone Ambulatory Care Garden City includes 260 patient exam rooms and a new, expanded adult ophthalmology service.
  • "NYU Langone's new state-of-the-art facility in Garden City will provide the top notch services they are known for, and add to the health of our community."
  • "This medical facility is a nice addition to our vibrant downtown," said Garden City Mayor Mary Carter Flanagan.